tert-Butyl (1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyrrolidin-3-yl)carbamate

Catalog No. :
ACXTRT175
CAS No. :
1357397-73-9
Molecular Formula :
C20H32BN3O4
Molecular Weight :
389.30

IUPAC Name:tert-butyl (1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyrrolidin-3-yl)carbamate

tert-Butyl (1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyrrolidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyrrolidin-3-yl)carbamate
IUPAC Nametert-butyl (1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyrrolidin-3-yl)carbamate
Molecular FormulaC20H32BN3O4
Molecular Weight389.30
SMILESO=C(OC(C)(C)C)NC1CN(C2=NC=C(B3OC(C)(C)C(C)(C)O3)C=C2)CC1
InChI KeyHZYOBEIZPHLEMM-UHFFFAOYSA-N
Synonymtert-butyl N-[1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]pyrrolidin-3-yl]carbamate;Carbamic acid, N-[1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]-3-pyrrolidinyl]-, 1,1-dimethylethyl ester
CAS No.1357397-73-9

Synthetic Route by SureRoute

1. ACXTRT175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACXTRT175 route product structure diagram
    ACXTRT1751357397-73-9
Inquiry

2. ACXTRT175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUIBR246 route compound structure diagram
    ACUIBR24699724-19-3 In Stock
  2. Plus
  3. ACXIZU058 route compound structure diagram
    ACXIZU058444120-94-9 In Stock
  4. Then
  5. ACXTRT175 route product structure diagram
    ACXTRT1751357397-73-9
Inquiry

Comments (0)